GlassScriptPhysician profile
Umesh Patel
NPI 1629070826
$5,296.74
in general payments reported to CMS, 2019-2025
37 companies · $767 in 2025
The $767 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,356 · 2020: $166 · 2021: $468 · 2022: $684 · 2023: $1,014 · 2024: $843 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,623.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $537.65 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $478.91 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $456.87 | 2021-2025 | Verquvo, Capvaxive, Belsomra |
| Janssen Pharmaceuticals, INC | $425.23 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $331.78 | 2020-2025 | |
| Pfizer INC. | $310.59 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $300.00 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $243.15 | 2019-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $215.78 | 2019-2025 | Camzyos |
| Medtronic, INC. | $213.27 | 2022-2025 | Selectsecure, Linq II, Cobalt Dr Mri Surescan |
| Lundbeck LLC | $210.74 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.85 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $183.56 | 2019-2022 | |
| Inspire Medical Systems, INC. | $137.58 | 2022-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $131.40 | 2019-2024 | Evkeeza |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $87.06 | 2021-2025 | Nexletol |
| Biotronik INC. | $82.17 | 2019 | |
| Scpharmaceuticals INC. | $73.30 | 2023-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $72.00 | 2021-2023 | Arcalyst |
| Astellas Pharma US INC | $59.42 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $52.58 | 2019-2022 | |
| Abiomed | $50.99 | 2023-2025 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $46.13 | 2021-2023 | |
| Atricure, INC. | $41.59 | 2024 | |
| Irhythm Technologies, INC. | $41.32 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $37.68 | 2024 | Arcalyst |
| Baxter Healthcare | $34.84 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Seqirus USA INC | $34.42 | 2019 | |
| Lilly USA, LLC | $32.58 | 2025 | Zepbound, Mounjaro |
| Boston Scientific Corporation | $31.08 | 2023 | Varithena Administration Pack |
| Daiichi Sankyo INC. | $27.41 | 2025 | Injectafer |
| Cvrx, INC. | $24.50 | 2023 | Barostim Neo System |
| Medtronic Vascular, INC. | $23.77 | 2019 | |
| Medicomp INC | $20.59 | 2024 | Telepatch Cardiac Monitor |
| Itamar Medical INC | $19.97 | 2023 | Watchpatone |
| Aimmune Therapeutics, INC. | $15.05 | 2024 | |
| Bardy Diagnostics, INC. | $5.93 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.